Verily, the precision health subsidiary of Alphabet, and Samsung Electronics have announced a comprehensive strategic collaboration aimed at revolutionizing the landscape of clinical research by integrating consumer wearable data into large-scale medical studies. The announcement, made during the HIMSS (Healthcare Information and Management Systems Society) global conference in Las Vegas, signals a significant shift in […]
In a definitive move to solidify its standing in the global hepatology market, the Italian pharmaceutical group Alfasigma has entered into a definitive agreement with GSK to acquire the global rights to linerixibat, a promising investigational treatment for cholestatic pruritus associated with primary biliary cholangitis (PBC). The deal, valued at an initial $300 million upfront, […]
The healthcare industry is currently navigating a period of profound transformation, driven by the convergence of labor shortages, rising administrative costs, and the rapid maturation of artificial intelligence. At the forefront of this evolution are technologies designed to bridge the gap between complex clinical workflows and the patient experience. Recent industry insights from leadership at […]
The landscape of the American healthcare system underwent a significant shift in February 2026 when Congress passed the Consolidated Appropriations Act of 2026, a massive spending package that included the first substantive federal restrictions on Pharmacy Benefit Managers (PBMs) in decades. These reforms specifically targeted the controversial "rebate" system by delinking PBM compensation from the […]
The global landscape for obesity therapeutics is currently dominated by GLP-1 (glucagon-like peptide-1) receptor agonists, which have demonstrated unprecedented efficacy in weight reduction but are frequently limited by significant gastrointestinal side effects. In a strategic move to diversify treatment options and improve patient adherence, Zealand Pharma and Roche have reported Phase 2 clinical trial results […]
The global pharmaceutical landscape witnessed a significant consolidation in the rare oncology sector this week as Servier, the independent international pharmaceutical company governed by a non-profit foundation, announced a definitive agreement to acquire Day One Biopharmaceuticals. The transaction, valued at approximately $2.5 billion, represents a decisive move by the French pharmaceutical giant to cement its […]
The landscape of employer-sponsored healthcare underwent a significant shift this week as Quantum Health, a leading provider of healthcare navigation and care coordination, announced its acquisition of CirrusMD, a prominent virtual care platform. This strategic transaction aims to fuse the logistical support of care navigation with the clinical immediacy of physician-led virtual care, creating a […]
In a strategic move to solidify its position within the rapidly evolving healthcare technology sector, Google Cloud has announced a series of significant updates to its artificial intelligence portfolio. The tech giant revealed a suite of new "agentic" AI capabilities powered by its Gemini and Vertex AI models, designed specifically to address the complex operational […]
The rapid expansion of artificial intelligence into the medical sector has reached a critical inflection point as industry leaders OpenAI and Anthropic transition from general-purpose large language models to specialized healthcare solutions. According to recent data from OpenAI, more than 40 million Americans now utilize ChatGPT on a daily basis to seek answers to healthcare-related […]
The modern healthcare landscape is currently undergoing a fundamental shift as industry leaders move beyond basic digitization toward sophisticated care orchestration and culturally tailored member support. In recent discussions with MedCity News, prominent executives from Arbiter and Clever Care Health Plan outlined the critical necessity of aligning technological innovation with the lived experiences of both […]
